Guardant Health Past Earnings Performance
Past criteria checks 0/6
Guardant Health's earnings have been declining at an average annual rate of -25.8%, while the Healthcare industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 23.1% per year.
Key information
-25.8%
Earnings growth rate
-22.3%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 23.1% |
| Return on equity | n/a |
| Net Margin | -74.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Guardant Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 692 | -512 | 505 | 342 |
| 30 Jun 24 | 644 | -491 | 463 | 349 |
| 31 Mar 24 | 604 | -461 | 454 | 356 |
| 31 Dec 23 | 564 | -479 | 451 | 365 |
| 30 Sep 23 | 536 | -432 | 458 | 381 |
| 30 Jun 23 | 510 | -508 | 474 | 387 |
| 31 Mar 23 | 482 | -665 | 477 | 382 |
| 31 Dec 22 | 450 | -655 | 464 | 369 |
| 30 Sep 22 | 431 | -606 | 442 | 338 |
| 30 Jun 22 | 408 | -551 | 420 | 309 |
| 31 Mar 22 | 391 | -419 | 400 | 287 |
| 31 Dec 21 | 374 | -406 | 399 | 263 |
| 30 Sep 21 | 344 | -409 | 398 | 230 |
| 30 Jun 21 | 324 | -379 | 390 | 196 |
| 31 Mar 21 | 298 | -336 | 357 | 168 |
| 31 Dec 20 | 287 | -254 | 299 | 150 |
| 30 Sep 20 | 271 | -185 | 239 | 135 |
| 30 Jun 20 | 258 | -120 | 183 | 124 |
| 31 Mar 20 | 245 | -77 | 154 | 107 |
| 31 Dec 19 | 214 | -76 | 140 | 86 |
| 30 Sep 19 | 184 | -76 | 128 | 77 |
| 30 Jun 19 | 145 | -87 | 115 | 67 |
| 31 Mar 19 | 111 | -97 | 102 | 59 |
| 31 Dec 18 | 91 | -85 | 90 | 51 |
| 30 Sep 18 | 78 | -75 | 74 | 42 |
| 30 Jun 18 | 67 | -84 | 76 | 35 |
| 31 Mar 18 | 57 | -83 | 69 | 29 |
| 31 Dec 17 | 50 | -89 | 66 | 26 |
| 31 Dec 16 | 25 | -46 | 36 | 11 |
Quality Earnings: GH * is currently unprofitable.
Growing Profit Margin: GH * is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GH * is unprofitable, and losses have increased over the past 5 years at a rate of 25.8% per year.
Accelerating Growth: Unable to compare GH *'s earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GH * is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (17.9%).
Return on Equity
High ROE: GH *'s liabilities exceed its assets, so it is difficult to calculate its Return on Equity.